Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
about
Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndromeT helper cell activation and human retroviral pathogenesisENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluidsHuman Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent VirusesKinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered ChimpanzeesWhy do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramersPatients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 moleculesDifferential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patientsPhenotypic analysis of antigen-specific T lymphocytesA significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimenAdministration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaquesAnti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiencyCD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genesAssociation between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection.Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val.Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.The challenge of immune control of immunodeficiency virusMemory CD8+ T cells in HIV infectionHuman immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapyEvaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines.Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine.Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors.Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.Cellular HIV-1 immune responses in natural infection and after genetic immunization.Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers.Cellular immune responses to HIV.HIV chemotherapy.Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 allelesCharacterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunizationHuman immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes.A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activationViral escape mechanisms--escapology taught by viruses.Development of immunotherapeutic strategies for HIV-1.
P2860
Q24516944-6F8F137F-2E93-4B76-9BFF-B30A1EE09ED1Q24531479-BF66DF97-CE1F-456E-8E2B-87BCD2690CD3Q24648628-8DED3549-AB24-4D07-93EE-583159058D98Q24650854-E9D6020F-D73A-4C39-8668-C2F349A58264Q24682788-83A82851-9230-408C-8AFD-4EE3EF5C88A5Q27472844-1AC74B1E-D5E1-41AA-A2E8-7BEDF1C9090AQ27473402-4FB6DB28-D165-4C41-A144-7FDDA6433203Q27477753-4024A3BA-E923-4951-82E1-0A70CBC4C498Q27478466-B6690D77-81DF-4E38-9950-87D16A58322AQ27480744-61EB7D80-35F8-4806-9525-7FBA31706C6EQ28290058-CC1F86BF-9986-4C2B-930C-B4073B865601Q33603919-2C5F584D-7DAB-47A1-83A7-48390B8BE22CQ33648533-E8924BA6-D3F4-4A28-8FAE-B87DF3EFDDF0Q33649842-B3E4BA5B-9860-402F-8F7A-C351C692E872Q33781916-AF0B1A85-E83E-4E83-8A0A-3E1296C47C3DQ33803446-32C807C8-F15C-4A3A-9308-9474E6D00266Q33804193-6CD5B8E4-6685-4FDE-8B3A-605FD81EC439Q33811112-12758D95-9889-4B7A-9CA6-0609137BF3BBQ33817504-D7CC3B6C-60E4-447C-983A-4A94111A786FQ33820365-70D5F8AB-E79E-45D0-84CA-2DF7A59A64ECQ33842057-40CA0CA0-90A7-4807-95E4-10F6ABEA077DQ33849823-E202F3A7-2598-48FA-B020-3D4C5DC0974EQ33854132-36176AEE-CED3-4CF3-83BB-6EBE60447CD7Q33905214-D32F1EDD-1B65-4453-9164-564E7C871E3AQ33952015-BEB44F2F-1A3C-416B-82DF-4CE1EAD7D33EQ33998189-7B3EDFA9-7BE9-40C8-B83D-D869D6278320Q34069815-E4A56AF7-CE81-4314-A1D6-F381143C4AE1Q34152088-491E5EA8-061D-45D4-9EC8-7B9D8615CB12Q34156338-7B0CF3F4-06A5-4D44-B8A0-768F7DFF74A7Q34172130-2A9D01A8-BC76-4A8B-AC48-2331826AF9AAQ34176576-005AE6AD-940A-4353-83FA-3297E9C700B2Q34223069-6A4D29FE-C404-4594-A810-3B5FD36C8836Q34223088-5F65B629-0E09-4E93-9731-A7DB50F5F83AQ34229490-7FA0233D-1414-4FE0-B724-88B81224BDADQ34339044-E728E3C1-2501-451E-A163-37CCAE9FEA9BQ34342413-7A6BEF31-B0B2-49D7-9F64-6FE05885746DQ34351301-BC3700FB-7698-44F0-A83B-9D4B927CDC47Q34356962-0491F095-4B6A-4368-A6FD-3E66EEF93F59Q34434767-1F32F5F4-51C2-49CA-B7C8-CF6C15ABA4D8Q34452629-9C9A7313-C198-4E72-AAE6-34A897E1B50E
P2860
Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Quantitative analysis of the h ...... in-Barr virus in late disease.
@ast
Quantitative analysis of the h ...... in-Barr virus in late disease.
@en
type
label
Quantitative analysis of the h ...... in-Barr virus in late disease.
@ast
Quantitative analysis of the h ...... in-Barr virus in late disease.
@en
prefLabel
Quantitative analysis of the h ...... in-Barr virus in late disease.
@ast
Quantitative analysis of the h ...... in-Barr virus in late disease.
@en
P2093
P2860
P921
P356
P1476
Quantitative analysis of the h ...... in-Barr virus in late disease.
@en
P2093
Borysiewicz L
Carmichael A
P2860
P304
P356
10.1084/JEM.177.2.249
P407
P577
1993-02-01T00:00:00Z